Molecular structure of Remoxipride Hydrochloride, CAS Number: 73220-03-8
Remoxipride Hydrochloride (CAS 73220-03-8)
Application:
Remoxipride Hydrochloride is a selective and potent D2RD agonist
CAS Number:
73220-03-8
Molecular Weight:
407.8
Molecular Formula:
C16H23BrN2O3•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Remoxipride Hydrochloride is used in research applications to study dopamine receptor antagonism and its effects on neurotransmitter pathways. This compound aids in exploring the dopaminergic system in the brain, particularly focusing on the D2 dopamine receptors. Research involving Remoxipride Hydrochloride helps in understanding the modulation of neurotransmission, which is for elucidating the role of dopamine in cognitive functions, such as memory and learning. Additionally, the use of Remoxipride Hydrochloride in experimental models facilitates investigations into the behavioral effects of altered dopamine receptor activity.
Remoxipride Hydrochloride (CAS 73220-03-8) References
- Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist. | Nadal, R. 2001. CNS Drug Rev. 7: 265-82. PMID: 11607043
- Atomic force microscopy analysis and confocal Raman microimaging of coated pellets. | Ringqvist, A., et al. 2003. Int J Pharm. 267: 35-47. PMID: 14602382
- Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models. | Högberg, T., et al. 1986. Mol Pharmacol. 30: 345-51. PMID: 2945089
- [A study of remoxipride dosage and plasma concentration. New psychopharmaceuticals should be followed-up more strictly]. | Mrtensson, E. and Nyberg, G. 1994. Lakartidningen. 91: 2948-9. PMID: 7990536
- Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. | Mohell, N., et al. 1993. Eur J Pharmacol. 238: 121-5. PMID: 8405075
- Accelerated dissolution rate analysis (ACDRA) for controlled release drugs. Application to Roxiam. | Zackrisson, G., et al. 1995. J Pharm Biomed Anal. 13: 377-83. PMID: 9696546
Inhibitor of:
D2DR.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Remoxipride Hydrochloride, 10 mg | sc-200410 | 10 mg | $338.00 | |||
Remoxipride Hydrochloride, 50 mg | sc-200410A | 50 mg | $575.00 |